ARM 24.174.1401. REQUIREMENTS FOR REGISTRATION

(1) The board shall register a person to manufacture dangerous drugs (as defined in 50-32-101 , MCA) included in Schedules I through V upon the following conditions: (a) applicant is registered for such purposes pursuant to the Federal Controlled Substances Act of 1970; (b) the applicant has made proper application and has paid the applicable fee; and (c) the category of manufacturer as above-stated shall include only those applicants who are engaged in the manufacturing of dangerous drugs within the state of Montana. (2) The board shall register a person or entity to distribute dangerous drugs included in Schedules I through V under the following conditions: (a) applicant is registered for such purpose pursuant to the Federal Controlled Substances Act of 1970; (b) the applicant has made proper application and paid the applicable fee; (c) the category of distributor as above-stated shall include any person or entity who distributes dangerous drugs or samples thereof within the state of Montana and may include a manufacturer not otherwise required to be registered if such manufacturer also distributes dangerous drugs or samples thereof within the state of Montana; and (d) representatives of drug manufacturers who distribute controlled substance samples to licensed practitioners shall be exempt from the requirement of registration. (3) The board shall register a person to analyze or conduct research with narcotic dangerous drugs in Schedules II through V upon making proper application and paying the applicable fee. (4) The board shall register a person to analyze or conduct research with dangerous drugs in Schedule I, if: (a) the applicant is a practitioner licensed under the laws of this state; (b) the applicant has furnished the board evidence of registration for such purpose pursuant to the Federal Controlled Substances Act of 1970; (c) the applicant has furnished the board a complete resume of all research proposed relative to any dangerous drugs. Such resume must be a duplicate of an application submitted to the DEA; and (d) the applicant has made proper application and paid the applicable fee.